Cargando…
CNS inflammation other than multiple sclerosis: How likely is diagnosis?
The incidence, diagnostic landscape, and workload impact of CNS inflammatory diseases other than multiple sclerosis (MS) (CIDOMS) in a tertiary setting is unknown. We describe a retrospective case series of 64 patients identified over a 2-year period (2009–2010) at the Wessex Neurological Centre in...
Autores principales: | Street, Duncan, Halfpenny, Christopher A., Galea, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966798/ https://www.ncbi.nlm.nih.gov/pubmed/24587479 http://dx.doi.org/10.1212/WNL.0000000000000273 |
Ejemplares similares
-
Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016) -
CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19
por: Pinto, Ashwin A., et al.
Publicado: (2020) -
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy
por: Rinaldi, Francesca, et al.
Publicado: (2017) -
Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014) -
Degos disease mimicking primary vasculitis of the CNS
por: Gmuca, Sabrina, et al.
Publicado: (2016)